Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevirapine 400mg vs 600mg in HIV/TB Co-infection
NCT00476853Phase 2Completed
- Sponsor
- HIV-NAT
- Start
- Oct 2005
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nevirapine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by HIV-NAT. Started Oct 2005; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00476853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476853.